Through a partnership with Medscape, CSRO publishes a bi-monthly advocacy column authored by Vice President of Advocacy & Government Affairs, Madelaine Feldman, MD.
Titled Rheum for Action, the column inspires individuals to make ‘rheum’ in their lives for action and keeps the rheumatology community updated on the latest advocacy issues affecting their work. Review all of the latest editions of the columns below.
Rheum for Action: Generic Tofacitinib: Will It Be a Bellwether for the Future of Expensive Generics?
March 28, 2025
READ COLUMN ⇒
Rheum for Action: Patients Before Monopolies Act: A Game Changer for Patients, Pharmacists, and Prices?
January 24, 2025
READ COLUMN ⇒
Rheum for Action: Abuse of the Safety-Net 340B Drug Pricing Program: Why Should Physicians Care?
November 18, 2024
READ MORE ⇒
Rheum for Action: ‘Reform School’ for Pharmacy Benefit Managers: How Might Legislation Help Patients?
September 17, 2024
READ MORE ⇒
Rheum for Action: Fed Worker Health Plans Ban Maximizers and Copay Accumulators: Why Not for the Rest of the US?
July 29, 2024
READ MORE ⇒
Rheum for Action: Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
May 16, 2024
READ MORE ⇒
Rheum for Action: ERISA Health Plan Lawsuits: Why Should We Care?
March 15, 2024
READ MORE ⇒
Rheum for Action: Biosimilar Business Deals Keep Up ‘Musical Chairs’ Game of Formulary Construction
January 17, 2024
READ MORE ⇒
Rheum for Action: Prescription drug affordability boards: Another quick fix with unintended consequences?
November 17, 2023
READ MORE ⇒
Rheum for Action: Insurer’s foray into AI-based ‘shared savings’ program creates ethical problems
September 20, 2023
READ MORE ⇒
Rheum for Action: In-office infusions at risk with new Medicare Part B reimbursement recommendation
July 6, 2023
READ MORE ⇒
Rheum for Action: Getting a white-bagging exemption: A win for the patient, employer, and rheumatologist
May 2, 2023
READ MORE ⇒
Rheum for Action: A little education goes a long way for advocacy
March 16, 2023
READ MORE ⇒
Rheum for Action: Unintended consequences of perfectly good programs and policies
January 18, 2023
READ MORE ⇒
Rheum for Action: Use 2022’s advocacy successes and frustrations as a catalyst for the new year
November 14, 2022
READ MORE ⇒
Rheum for Action: Employers’ self-funded health plans can leave rheumatology patients vulnerable
September 20, 2022
READ MORE ⇒
Rheum for Action: Who’s in charge here? Rheumatologists battle local Medicare policies threatening access, practice sustainability
July 21, 2022
READ MORE ⇒
Rheum for Action: Will ‘gold card’ legislation and others rein in prior authorizations?
May 23, 2022
READ MORE ⇒
Rheum for Action: New law will awaken employers to health care’s ‘transparency gap’
March 16, 2022
READ MORE ⇒
Rheum for Action: Could stopping ‘thousand cuts’ by insurers and PBMs help rheumatology’s workforce shortage?
January 19, 2022
READ MORE ⇒
Rheum for Action: Taking 2021’s rheumatology advocacy momentum into 2022
November 12, 2021
READ MORE⇒
Rheum for Action: Beware patients’ health plans that skirt state laws on specialty drug access
September 20, 2021
READ MORE ⇒
Rheum for Action: Legislative wins set groundwork for future success
July 16, 2021
READ MORE ⇒
Rheum for Action: How I got started in advocacy
May 12, 2021
READ MORE ⇒
